Congenital and acquired bleeding disorders in pregnancy

Acquired bleeding disorders.

tial acquired bleeding disorder is common in clinical practice. The most common cause is anticoagulant therapy, including antiplatelet drugs. With increasing use of pharmacological thromboprophylaxis in both medical and surgical inpatients and increasing indications for long-term antithrombotic therapy, it is imperative to consider drug-induced bleeding during the initial evaluation of abnormal...

Congenital bleeding disorders.

Both clinical and basic problems related to the congenital bleeding disorders continue to confront hematologists. On the forefront are efforts to bring genetic correction of the more common bleeding disorders such as hemophilia A to the clinic in a safe and accessible manner. A second issue, particularly for patients with hemophilia, is the development of inhibitors-questions of how they arise ...

Outcomes of Congenital Bleeding Disorders

Result: Thirty-one patients (48.4%) were diagnosed with hemophilia A,eighteen patients (28.1%) had von Willebrand disease, eleven patients (17.9%) had Hemophilia B and four patients had other factor deficiencies. Elevenpatients with Hemophilia A and one patient with Hemophilia B had severe disease. The prevalence of hepatitis C virus infection was 5%. All patients were negative for hepatitis B ...

Management of Inherited Bleeding Disorders in Pregnancy

Italian Registry of Congenital Bleeding Disorders

In Italy, the surveillance of people with bleeding disorders is based on the National Registry of Congenital Coagulopathies (NRCC) managed by the Italian National Institute of Health (Istituto Superiore di Sanità). The NRCC collects epidemiological and therapeutic data from the 54 Hemophilia Treatment Centers, members of the Italian Association of Hemophilia Centres (AICE). The number of people...